DALL'ORA, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 827
EU - Europa 533
AS - Asia 191
AF - Africa 45
SA - Sud America 3
OC - Oceania 2
Totale 1.601
Nazione #
US - Stati Uniti d'America 817
IT - Italia 137
GB - Regno Unito 132
CN - Cina 91
SE - Svezia 74
DE - Germania 71
VN - Vietnam 50
IN - India 30
TG - Togo 23
IE - Irlanda 21
RU - Federazione Russa 19
FR - Francia 17
BG - Bulgaria 13
BE - Belgio 12
CI - Costa d'Avorio 11
JO - Giordania 11
CA - Canada 10
EE - Estonia 10
ZA - Sudafrica 10
UA - Ucraina 8
NL - Olanda 4
SG - Singapore 4
DK - Danimarca 3
ES - Italia 3
FI - Finlandia 3
AU - Australia 2
BR - Brasile 2
CH - Svizzera 2
CO - Colombia 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
KR - Corea 1
MN - Mongolia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 1.601
Città #
Southend 115
Fairfield 105
Chandler 98
Ashburn 82
Ann Arbor 75
Woodbridge 62
Dong Ket 50
Bologna 45
Seattle 44
Wilmington 44
Cambridge 40
Houston 40
Princeton 29
Lomé 23
Dublin 21
Beijing 17
Turin 14
Redmond 13
Sofia 13
Westminster 13
Brussels 12
Abidjan 11
Amman 11
Berlin 10
Bremen 10
Nanjing 10
Padova 10
Ottawa 9
San Diego 9
Changsha 6
Jinan 6
Saint Petersburg 6
Delhi 5
Guangzhou 5
Jiaxing 5
Nanchang 5
Redwood City 5
Shenyang 5
Amsterdam 4
Boardman 4
Des Moines 4
Hebei 4
Milan 4
Reggio Nell'emilia 4
Shanghai 4
Tianjin 4
Chieti 3
Haikou 3
Lanzhou 3
Nærum 3
Phoenix 3
Portici 3
Rome 3
Singapore 3
Bühl 2
Dearborn 2
Helsinki 2
Las Vegas 2
London 2
Montechiarugolo 2
Ningbo 2
Portomaggiore 2
Romainville 2
San Giorgio di Piano 2
São Paulo 2
Taiyuan 2
Taizhou 2
Vedelago 2
Bern 1
Bochum 1
Bogotá 1
Bratislava 1
Brno 1
Budapest 1
Bulle 1
Cagliari 1
Canberra 1
Candiolo 1
Central 1
Centro 1
Cordenons 1
Falkenstein 1
Grafing 1
Hangzhou 1
Hefei 1
Huzhou 1
Jakarta 1
Kiev 1
Lansing 1
Lappeenranta 1
Los Angeles 1
Medford 1
Norwalk 1
Olalla 1
Radcliffe 1
Riccione 1
Stockholm 1
Sydney 1
Toronto 1
Trieste 1
Totale 1.199
Nome #
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft 224
Calreticulin: Challenges Posed by the Intrinsically Disordered Nature of Calreticulin to the Study of Its Function 152
Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus. 148
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases 138
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2. 123
null 121
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 115
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. 108
Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer 102
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 102
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas 92
Chemical Compositions of Field and Globular Cluster RR Lyrae Stars. II. ω Centauri 87
On the Use of Field RR Lyrae as Galactic Probes. I. The Oosterhoff Dichotomy Based on Fundamental Variables 71
Using RR Lyrae Stars as High-Precision Distance Indicators in the Infrared 53
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors 30
Totale 1.666
Categoria #
all - tutte 4.197
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.197


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020411 45 11 1 17 46 30 57 55 68 48 20 13
2020/2021328 48 16 12 7 3 2 22 75 35 12 13 83
2021/2022304 16 19 30 15 37 17 8 20 13 19 72 38
2022/2023395 39 61 25 60 27 27 12 28 58 18 30 10
2023/2024100 7 18 5 12 9 12 3 21 1 4 4 4
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 1.666